Using our previously described experimental conditions for B cell activation [15], we have to date functionally screened over 40 PAD patients who were suspected or diagnosed with CVID by their clinicians because of their clinical presentation, low serum IgG and IgA, and a lack of humoral response to polysaccharides at presentation. This evidence concerns the gene CD79A and common variable immunodeficiency.